Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.1.71NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AS.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AS.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AS.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.142NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.142NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.142NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.166NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.166NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.166NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.4.11 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.4.11 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.11 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.4NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.4NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AY.34.2 (Delta)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AY.34.2 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.34.2 (Delta)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.50NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.50NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.50NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.60NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.60NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.60NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.52NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.52NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.52NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
W.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
W.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
W.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.250NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.250NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.250NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.177.63NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.177.63NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.63NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.27NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.27NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.23NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.130NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.130NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.130NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.44NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.44NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.44NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.469NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used